3,4,5-Trihydroxyphenethyl Alcohol

3,4,5-Trihydroxyphenethyl Alcohol

SCHEMBL2990691

OCCc1cc(O)c(O)c(O)c1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
MAPT P10636 3/20 0.58
ALDH1A1 P00352 2/20 0.58
GAA P10253 2/20 0.58
ALOX5 P09917 1/20 0.58
BACE1 P56817 1/20 0.58
CA2 P00918 2/20 0.46
TDP1 Q9NUW8 3/20 0.42
MAPK1 P28482 3/20 0.39
ADRA2A P08913 2/20 0.39
DRD2 P14416 2/20 0.39
DRD1 P21728 2/20 0.39
DRD4 P21917 2/20 0.39
DRD5 P21918 2/20 0.39
SLC6A2 P23975 2/20 0.39
DRD3 P35462 2/20 0.39
RECQL P46063 2/20 0.39
SLC6A3 Q01959 2/20 0.39
ALOX15 P16050 2/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12837356 0.87 BACE1 (0.52) KDM4EMAPTALDH1A1GAAALOX5
SCHEMBL2986688 0.84 TNKS2 (0.52) KDM4EMAPTALDH1A1GAAALOX5
SCHEMBL63871 0.78 TDP1 (0.53) KDM4EMAPTALDH1A1GAAALOX5
SCHEMBL328576 0.78 TDP1 (0.62) KDM4EMAPTALDH1A1GAABACE1
SCHEMBL17138365 0.78 TDP1 (0.62) KDM4EMAPTALDH1A1GAABACE1
SCHEMBL13555306 0.77 BACE1 (0.42) KDM4EMAPTALDH1A1GAAALOX5
SCHEMBL68262 0.77 ACHE (0.55) KDM4EMAPTALDH1A1GAAALOX5
SCHEMBL723983 0.76 LTA4H (0.58) BACE1
Water SCHEMBL17686500 0.76 TDP1 (0.60) KDM4EMAPTALDH1A1GAABACE1
Hydrochloric Acid SCHEMBL3757551 0.76 TDP1 (0.64) KDM4EMAPTALDH1A1GAABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104177393-A Photosensitizer, and preparation method and application thereof SHENZHEN CHINA RESOURCES GOSUN PHARMACEUTICAL CO LTD 2014-12-03 CN claimed
CN-120136704-A Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound 三菱瓦斯化学株式会社 2025-06-13 CN disclosed
CN-120136703-A Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound 三菱瓦斯化学株式会社 2025-06-13 CN disclosed
CN-119472193-A Low-corrosion and easy-to-clean chip photoresist stripping liquid, and preparation method and application thereof 浙江奥首材料科技有限公司 2025-02-18 CN disclosed
CN-115838322-B Polymerization inhibiting composition for olefin compounds and polymerization inhibiting method 杭州唯铂莱生物科技有限公司 2024-03-29 CN disclosed
CN-115838322-A Polymerization inhibiting composition for olefin compound and polymerization inhibiting method 杭州唯铂莱生物科技有限公司 2023-03-24 CN disclosed
US-20220348698-A1 COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND, AS WELL AS METHOD FOR PRODUCING IODINE-CONTAINING VINYL POLYMER AND ACETYLATED DERIVATIVE THEREOF MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-11-03 US disclosed
US-20210347804-A1 COMPOUNDS, COMPOSITIONS AND METHOD FOR COLORING EDIBLE MATERIALS THE PENN STATE RESEARCH FOUNDATION 2021-11-11 US disclosed
US-11001601-B2 Compounds, compositions and methods for coloring edible materials THE PENN STATE RESEARCH FOUNDATION (US) 2021-05-11 US disclosed
EP-3370523-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR COLORING EDIBLE MATERIALS The Penn State Research Foundation (US) 2018-09-12 EP disclosed
WO-2012113371-A1 DETECTION OF DIMERIC CATECHOLAMINE METABOLITES AS INDICATORS OF NEURODEGENERATIVE DISEASES Thanares GmbH (DE) 2012-08-30 WO disclosed
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 US disclosed
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 US disclosed
EP-0993481-B1 METHOD FOR PRODUCING BRANCHED POLYCARBONATES BAYER MATERIALSCIENCE AG (DE) 2008-03-05 EP disclosed
EP-0708130-B1 Production of branched polycarbonates by an equilibration process GEN ELECTRIC (US) 2003-09-10 EP disclosed
US-5597887-A MELT TRANSESTERIFICATION FOR POLYCARBONATES GENERAL ELECTRIC COMPANY (US) 1997-01-28 US disclosed
EP-0708130-A1 Production of branched polycarbonates by an equilibration process GENERAL ELECTRIC COMPANY (US) 1996-04-24 EP disclosed
US-5191038-A Preparation of branched polycarbonate composition from cyclic aromatic polycarbonate oligomer, polyhydric phenol and polycarbonate GENERAL ELECTRIC COMPANY (US) 1993-03-02 US disclosed
US-5097008-A Tetraphenylborate catalyst, melt strength GENERAL ELECTRIC COMPANY (US) 1992-03-17 US disclosed
EP-0400478-A2 Branched polycarbonates and method of preparation GENERAL ELECTRIC COMPANY (US) 1990-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents TYR, MMP17, MMP1 KDM4E 1048/4885MAPT 3248/4885ALDH1A1 567/4885
US-11001601-B2 Compounds, compositions and methods for coloring edible materials IK, ACACA, ABHD5 KDM4E 1188/4885MAPT 647/4885ALDH1A1 1462/4885
US-20210347804-A1 COMPOUNDS, COMPOSITIONS AND METHOD FOR COLORING EDIBLE MATERIALS IK, ACACA, GRAMD1A KDM4E 1504/4885MAPT 659/4885ALDH1A1 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.